ArticleFrontiers in pharmacology2025

Case Report: Infliximab for hydroxychloroquine-induced AGEP with IL17A and IL36RN mutations: a case report and management considerations.

Xiaoyun Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.